BTNL9 exerts anti-cancer effects by inhibiting CDC20 to induce G2/M arrest in pancreatic cancer

Figure 5 Effects of BTNL9/CDC20 on proliferation, migration, and cell cycle of pancreatic cancer cells. A: Pancreatic cancer cells were transfected with BTNL9 and CDC20; B: The proliferative ability of four types of cells in the CCK8 assay; C: Transwell assay was used to analyze the migration capacity in four types of cells; D: The cell cycle distribution of cells was measured by flow cytometry. ^aP < 0.05, ^bP < 0.01, ^cP < 0.001.